Actionable news
0
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Sarepta rockets 20% higher after 'powerhouse' biotech tops revenue expectations

Sarepta Therapeutics stock surged by 20 percent after the company brought in much higher-than-expected revenues in its second-quarter earnings report Wednesday.

Wall Street believes the biopharmaceutical company's focus on developing treatments for rare neuro-muscular diseases is paying off, putting Sarepta in position to dominate its sector of the commercial drug market.

"We believe Sarepta is on track to become a [Duchenne Muscular Dystrophy]-focused powerhouse,"...


More